Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xin Huanghe Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in a diverse portfolio of traditional Chinese medicines (TCM) and chemical generic drugs. The company is a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., leveraging extensive production capabilities to supply essential medicines across cardiovascular, respiratory, and anti-infective therapeutic areas. Their product line features well-known brands such as Compound Danshen tablets and a variety of over-the-counter (OTC) analgesics and vitamins. Operating under strict GMP standards, the firm maintains a significant presence in the domestic Chinese market while expanding its reach through the Shanghai Pharma distribution network. The company serves as a critical manufacturing hub for high-volume oral solid dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xin Huanghe Pharmaceutical.